2021 Annual Meeting Biologics Access Pass-The Use of Autogenous Tissue as OrthoBiologic Therapy: What Are the Options and Do they Really Work?

The Use of Autogenous Tissue as OrthoBiologic Therapy: What Are the Options and Do they Really Work?

Video Transcription

Video Summary

In this video, the speaker discusses autogenous cells in sports medicine. They mention the FDA's enforcement of orthobiologics and the use of autogenous tissue in treatments. They also talk about the definition of mesenchymal stem cells (MSCs) and the criteria that must be met for a cell to be classified as an MSC. The speaker highlights PRP and adipose as the best options currently available for cellular therapies in sports medicine, with PRP being effective for tendinopathies and leukocyte-poor PRP being effective for early osteoarthritis. They also discuss the benefits of adipose over marrow and share their personal experience treating over 300 athletes. They mention the need for more research and provide examples of studies and evidence supporting the use of cellular therapies. Overall, the speaker believes that cellular therapies show promise and provide safe pain relief, but more research is needed to fully understand their effectiveness.

Asset Caption

Dr. Claude Moorman

Meta Tag

Concept FDA Trial Requirement

Concept Autologous Cell-Based Orthobiologic Therapy

Concept Platelet-Rich Plasma

Concept Adipose-Derived Product

Concept Orthobiologics

Keywords

autogenous cells

sports medicine

FDA enforcement

mesenchymal stem cells

cellular therapies

FDA Trial Requirement

Autologous Cell-Based Orthobiologic Therapy

Platelet-Rich Plasma

Adipose-Derived Product

Orthobiologics